The effects of bromocriptine on attention deficits after traumatic brain injury: A placebo-controlled pilot study

American Journal of Physical Medicine and Rehabilitation

Volumn 87, Issue 2, 2008, Pages 85-99

  Whyte, John ^a,b   Vaccaro, Monica ^a   Grieb Neff, Patricia ^a   Hart, Tessa ^a,b   Polansky, Marcia ^c   Coslett, H Branch ^a,d  

^a MOSS REHABILITATION RESEARCH INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c DREXEL UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Attention Deficit; Bromocriptine; Traumatic Brain Injury

Indexed keywords

BROMOCRIPTINE; PLACEBO;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECREASED APPETITE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HALLUCINATION; HEART PALPITATION; HEARTBURN; HUMAN; IRRITABILITY; MALE; MICTURITION DISORDER; NAUSEA; NERVOUSNESS; PROBABILITY; PRURITUS; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; TRAUMATIC BRAIN INJURY; TREMOR; UNSPECIFIED SIDE EFFECT; VIDEORECORDING; VITAL SIGN; VOMITING; WEAKNESS; WILCOXON SIGNED RANKS TEST; XEROSTOMIA;

ADOLESCENT; ADULT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN INJURIES; BROMOCRIPTINE; COGNITION DISORDERS; CROSS-OVER STUDIES; DISABILITY EVALUATION; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUESTIONNAIRES; REACTION TIME; STATISTICS, NONPARAMETRIC;

EID: 38349161994     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3181619609     Document Type: Article

References (30)

1. McAllister TW: Mild traumatic brain injury and the postconcussive syndrome, in Silver JM, Yudofsky SC, Hales RE (eds): Neuropsychiatry of Traumatic Brain Injury. Washington, DC, American Psychiatric Press, 1994, pp 357-92
2. Whyte J, Schuster K, Polansky M, et al: Frequency and duration of inattentive behavior after traumatic brain injury: effects of distraction, task and practice. J Int Neuropsychol Soc 2000;6:1-11
3. Whyte J: Attentional function after traumatic brain injury: what's impaired, what's preserved and why?, in Ponsford J, Snow P, Anderson V (eds): International Perspectives in Traumatic Brain Injury. Fifth International Association for the Study of Traumatic Brain Injury. Melbourne, Australian Academic Press, 1998, pp 154-9
4. Kim J, Whyte J, Hart T, et al: Executive function as a predictor of inattentive behavior after traumatic brain injury. J Int Neuropsychol Soc 2005;11:434-45
5. McDowell S, Whyte J, D'Esposito M: Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998;121:1155-64
6. Efron D, Jarman F, Barker M: Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100:1-7
7. Volkow ND, Wang GJ, Fowler JS, et al: Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001;21:1-5
8. Hoffman BB: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, in Hardman JG, Limbird LE (eds): The Pharmacological Basis of Therapeutics. New York, The McGraw-Hill Companies, Inc., 2001, pp 215-268
9. Whyte J, Hart T, Vaccaro M, et al: The effects of methylphenidate on attention deficits after traumatic brain injury: a multi-dimensional randomized controlled trial. Am J Phys Med Rehabil 2004;83:401-20
10. Kline AE, Massucci JL, Marion DW, et al: Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma 2002;19:415-25
11. Kimberg D, D'Esposito M, Farah MJ: Effects of bromocriptine on human subjects depend on working memory capacity. NeuroReport 1997;8:3581-5
12. Kimberg DY, Aguirre GK, Lease J, et al: Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. Hum Brain Mapp 2001;12:246-57
13. Piccirilli M, Piccinin GL, D'Alessandro P, et al: Cognitive performances in Parkinsonians before and after bromocriptine therapy. Clin Neurol 1985:167-72
14. McMillan TM, Jongen ELMM, Greenwood RJ: Assessment of post-traumatic amnesia after severe closed head injury: retrospective or prospective? J Neurol Neurosurg Psychiatry 1996;60:422-7
15. Rappaport M, Hall KM, Hopkins K, et al: Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil 1982;63:118-23
16. Barona A, Reynolds CR, Chastain R: A demographically based index of pre-morbid intelligence for the WAIS-R. J Consult Clin Psychol 1984;52:885-7
17. Whyte J, Polansky M, Fleming M, et al: Sustained arousal and attention after traumatic brain injury. Neuropsychologia 1995;33:797-813
18. Whyte J, Fleming M, Polansky M, et al: The effects of visual distraction following traumatic brain injury. J Int Neuropsychol Soc 1998;4:126-36
19. McDowell SK, Whyte J, D'Esposito M: Working memory impairments in traumatic brain injury: evidence from a dual-task paradigm. Neuropsychologia 1997;35:1341-53
20. Robertson IH, Manly T, Andrade J, et al: 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 1997;35:747-58
21. Robertson IH, Ward T, Ridgeway V, et al: The structure of normal human attention: The Test of Everyday Attention. J Int Neuropsychol Soc 1996;2:525-34
22. Whyte J, Polansky M, Cavallucci C, et al: Inattentive behavior after traumatic brain injury. J Int Neuropsychol Soc 1996;2:274-81
23. Broadbent DE, Cooper PF, FitzGerald P, et al: The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982;21:1-16
24. Ponsford J, Kinsella G: The use of a rating scale of attentional behavior. Neuropsychol Rehabil 1991;1:241-57
25. 82Br] bromocriptine. J Pharmacol Exp Ther 1979;211:31-5
26. Deleu D, Northway MG, Hanssens Y: Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease. Clin Pharmacokinet 2002;41:263-309
27. Luciana M, Depeu RA, Arbisi P, et al: Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 1992;4:58-68
28. Meltzer HY: Dopamine autoreceptor stimulation: clinical significance. Pharmacol Biochem Behav 1982;17:1-10
29. Kimberg D, D'Esposito M: Cognitive effects of the dopamine receptor agonist pergolide. Neuropsychologia 2003;41:1020-7
30. Muller U, Cramon YV, Pollmann S: D1-versus D2 receptor modulation of visuospatial working memory in humans. J Neurosci 1998;18:2720-8